Lv1
10 积分 2024-06-22 加入
Identification of narciclasine as a novel NRF2 inhibitor
1天前
已完结
Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
1个月前
已完结
Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders
3个月前
已完结
Discovery of Novel PROTAC SIRT6 Degraders with Potent Efficacy against Hepatocellular Carcinoma
3个月前
已完结
Selective and Orally Bioavailable c-Met PROTACs for the Treatment of c-Met-Addicted Cancer
3个月前
已完结
IMR-261, a Novel Oral Nrf2 Activator, Induces Fetal Hemoglobin in Human Erythroblasts, Reduces VOCs, and Ameliorates Ineffective Erythropoiesis in Experimental Mouse Models of Sickle Cell Disease and Beta-Thalassemia
9个月前
已完结
Itaconate trims the fat
10个月前
已完结
An updated patent review of Nrf2 activators (2020-present)
11个月前
已完结
Recent developments of HSP90 inhibitors: an updated patent review (2020-present)
11个月前
已完结
皖公网安备34019202002308
